Abstract:Women may experience differing types of pain and discomfort following birth, including cramping pain (often called after‐birth pain) associated with uterine involution, where the uterus contracts to reduce blood loss and return the uterus to its non‐pregnant size. This is an update of a review first published in 2011. To assess the effectiveness and safety of pharmacological and non‐pharmacological pain relief/analgesia for the relief of after‐birth pains following vaginal birth. For this update, we searched Cochrane Pregnancy and Childbirth's Trials Register, ClinicalTrials.gov , the WHO International Clinical Trials Registry Platform ( ICTRP ) (31 October 2019), and reference lists of retrieved studies. Randomised controlled trials comparing two different types of analgesia or analgesia versus placebo or analgesia versus no treatment, for the relief of after‐birth pains following vaginal birth. Types of analgesia included pharmacological and non‐pharmacological. Quasi‐randomised trials were not eligible for inclusion. Two review authors independently assessed trials for inclusion, conducted 'Risk of bias' assessment, extracted data and assessed the certainty of the evidence using the GRADE approach. In this update, we include 28 studies (involving 2749 women). The evidence identified in this review comes from middle‐ to high‐income countries. Generally the trials were at low risk of selection bias, performance bias and attrition bias, but some trials were at high risk of bias due to selective reporting and lack of blinding. Our GRADE certainty of evidence assessments ranged from moderate to very low certainty, with downgrading decisions based on study limitations, imprecision, and (for one comparison) indirectness. Most studies reported our primary outcome of adequate pain relief as reported by the women. No studies reported data relating to neonatal adverse events, duration of hospital stay, or breastfeeding rates. Almost half of the included studies (11/28) excluded breastfeeding women from participating, making the evidence less generalisable to a broader group of women. Non‐steroidal anti‐inflammatory drugs (NSAIDs) compared to placebo NSAIDs are probably better than placebo for adequate pain relief as reported by the women (risk ratio (RR) 1.66, 95% confidence interval (CI) 1.45 to 1.91; 11 studies, 946 women; moderate‐certainty evidence). NSAIDs may reduce the need for additional pain relief compared to placebo (RR 0.15, 95% CI 0.07 to 0.33; 4 studies, 375 women; low‐certainty evidence). There may be a similar risk of maternal adverse events (RR 1.05, 95% CI 0.78 to 1.41; 9 studies, 598 women; low‐certainty evidence). NSAIDs compared to opioids NSAIDs are probably better than opioids for adequate pain relief as reported by the women (RR 1.33, 95% CI 1.13 to 1.57; 5 studies, 560 women; moderate‐certainty evidence) and may reduce the risk of maternal adverse events (RR 0.62, 95% CI 0.43 to 0.89; 3 studies, 255 women; low‐certainty evidence). NSAIDs may be better than opioids for the need for additional pain relief, but the wide CIs include the possibility that the two classes of drugs are similarly effective or that opioids are better (RR 0.37, 95% CI 0.12 to 1.12; 2 studies, 232 women; low‐certainty evidence). Opioids compared to placebo Opioids may be better than placebo for adequate pain relief as reported by the women (RR 1.26, 95% CI 0.99 to 1.61; 5 studies, 299 women; low‐certainty evidence). Opioids may reduce the need for additional pain relief compared to placebo (RR 0.48, 95% CI 0.28 to 0.82; 3 studies, 273 women; low‐certainty evidence). Opioids may increase the risk of maternal adverse events compared with placebo, although the certainty of evidence is low (RR 1.59, 95% CI 0.99 to 2.55; 3 studies, 188 women; low‐certainty evidence). Paracetamol compared to placebo Very low‐certainty evidence means we are uncertain if paracetamol is better than placebo for adequate pain relief as reported by the women, the need for additional pain relief, or risk of maternal adverse events (2 studies, 123 women). Paracetamol compared to NSAIDs Very low‐certainty evidence means we are uncertain if there are any differences between paracetamol and NSAIDs for adequate pain relief as reported by the women, or the risk of maternal adverse events. No data were reported about the need for additional pain relief comparing paracetamol and NSAIDs (2 studies, 112 women). NSAIDs compared to herbal analgesia We are uncertain if there are any differences between NSAIDs and herbal analgesia for adequate pain relief as reported by the women, the need for additional pain relief, or risk of maternal adverse events, because the certainty of evidence is very low (4 studies, 394 women). Transcutaneous nerve stimulation (TENS) compar -Abstract Truncated-

Non-pharmacological treatments for shivering post neuraxial anaesthesia for caesarean section: a scoping review

Comparative efficacy of intravenous treatments for perioperative shivering in patients undergoing caesarean delivery under neuraxial anaesthesia: A systematic review and Bayesian network meta-analysis of randomised-controlled trials

Efficacy Of Dexmedetomidine As A Neuraxial Adjuvant For Elective Cesarean Sections: A Meta-Analysis Of Randomized Trials

Risk factors associated with intraoperative shivering during caesarean section: a prospective nested case-control study

The relationship between core temperature and perioperative shivering during caesarean section under intrathecal anesthesia with bupivacaine and ropivacaine: a randomized controlled study

Intrathecal Meperidine Decreases Shivering During Cesarean Delivery Under Spinal Anesthesia

Low dose of tramadol preconditioning preventing prophylaxis of shivering during subarachnoid anaesthesia for cesarean section: a randomized double-blind placebo-controlled clinical trial

Intrathecal Sufentanil Does Not Reduce Shivering During Neuraxial Anesthesia: A Meta-Analysis

Prophylactic norepinephrine infusion to treat hypotension after spinal anaesthesia during caesarean section: a meta-analysis

Intravenous Bolus of Dexmedetomidine for Treatment of Severe Shivering After Caesarean Delivery Under Combined Spinal-Epidural Anaesthesia: A Randomized Dose-Response Study

Medications for the prevention of pruritus in women undergoing cesarean delivery with Intrathecal morphine: A systematic review and bayesian network meta-analysis of randomized controlled trials

Continuous Intravenous Infusion of Remifentanil Improves the Experience of Parturient Undergoing Repeated Cesarean Section under Epidural Anesthesia, a Prospective, Randomized Study.

A Retrospective Study of Risk Factors and Prevention for Shivering after Intrathecal Anesthesia

Comparison of Intravenous Ondansetron versus Intravenous Tramadol on Post-Spinal Shivering and Nausea/Vomiting in Cesarean Sections

Comparison the Efficacy of Ketamine on the Patients Undergoing Elective Surgery for Prevention of Postoperative Shivering

Clinical Observation of Tramadol and Metoclopramide in Treatment of Shivering During Cesarean Section

Serotonin receptor antagonists for the prevention and treatment of pruritus, nausea, and vomiting in women undergoing cesarean delivery with intrathecal morphine: a systematic review and meta-analysis

Effect of Intravenous Calcium Gluconate on Prevention of Post Spinal Hypotension during Spinal Anaesthesia for Caesarean Section: A Randomized Double-Blind Controlled Study

Relief of pain due to uterine cramping/involution after birth.

Efficacy and Safety of Intrathecal Morphine for Cesarean Delivery: A Narrative Review

Prophylactic norepinephrine infusion or leg wrapping for postspinal hypotension in elective caesarean delivery: A randomised, double-blind, placebo-controlled trial